BioSpace News Archive

The special supplement examines strategies, best practices and technologies to make dentistry as safe as possible for clinicians and patients in the COVID-19 health care environment

In reaction to the dodgy deals that the drug industry is concocting to profit from the COVID 19 pandemic, AIDS Healthcare Foundation (AHF) today called on the U.S. government today to use its patent and “march-in” rights under section 1498 of the U.S. cod

Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that Jeff Nugent, President and Chief Executive Officer, will participate in a virtual webinar panel discussion hosted by Maxim Group and M-Vest on Thursday July 16 th , 2020.The panel discussion, Beauty after the Beast – Aesthetics during COVID-19 , is part of Maxim’s COVID-19 Virtual Conference Series: Re-Engaging Medical Practices in an Era of COVID-19.

Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in a panel discussion as part of the Re-Engaging Medical Practices in an Era of COVID-19 webinar, presented by Maxim Group and M-Vest, at 11:00 a.m. ET on Thursday, July 16, 2020. The panel di

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced the closing of its initial public offering of 16,100,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to 2,100,000 additional shares of common stock, at a public offering price of $18.00 per share. The aggregate

Empirical Spine, Inc., a Silicon-Valley based medical technology company, announced today that data from the IDE study of the company’s LimiFlex Paraspinous Tension Band for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis, will be presented at the 27th International Meeting on Advanced Spine Techniques

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced today the commencement of a proposed underwritten public offering of 8,000,000 shares of its common stock (6,000,000 of which are being offered for sale by Adaptive and 2,000,000 of which are being offered for sale by a selling sha

Eyelit Inc. announced top line revenue growth of over 25% for the first quarter of 2020 over the same period in 2019, despite lower services revenue due to COVID-19.

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / July 14, 2020 / MorphoSys AG (FSE:MOR); Prime Standard Segment; MDAX & TecDAX; (NASDAQ:MOR) announced today that its licensee Janssen Research & Development, LLC (Janssen) announced the U.S. Food and Drug Administration (FDA) approval of Tremfya (R) (guselkumab) as a treatment for adult patients living with active psoriatic arthritis (PsA). Active PsA is a chronic progressive disease characterized by painful joints and skin inflammation. A

Advanced Data Systems RCM is pleased to announce that clients of its MedicsRCM service derive enhanced revenue from coronavirus-related claims.